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BW

:   body weight

CHF

:   congestive heart failure

CI

:   confidence interval

CKCS

:   Cavalier King Charles Spaniel

CV

:   coefficient of variation

FS

:   fractional shortening

h/R

:   diastolic LV posterior wall thickness relative to LV internal diastolic radius

HR

:   hazard ratio

LA/Ao

:   left atrial‐to‐aortic root ratio

LVIDD

:   left ventricular end‐diastolic diameter

LVIDD~N~

:   left ventricular end‐diastolic diameter normalized for BW

LVIDS

:   left ventricular end‐systolic diameter

LVIDS~N~

:   left ventricular end‐systolic diameter normalized for BW

LV

:   left ventricular

LVPWD

:   left ventricular free wall thickness in diastole

MMVD

:   myxomatous mitral valve disease

MR

:   mitral regurgitation

MVP

:   mitral valve prolapse

Myxomatous mitral valve disease (MMVD) is the most common cardiovascular disease in dogs with a preponderance of middle‐ to old‐aged, small‐breed, male dogs.[1](#jvim14759-bib-0001){ref-type="ref"}, [2](#jvim14759-bib-0002){ref-type="ref"} MMVD is often regarded as a relatively benign condition.[3](#jvim14759-bib-0003){ref-type="ref"} However, in some dogs, the disease will progress and cause congestive heart failure (CHF) due to long‐standing left ventricular and left atrial volume overload.[3](#jvim14759-bib-0003){ref-type="ref"} Particularly, in the Cavalier King Charles Spaniel (CKCS), MMVD is associated with earlier onset and thus with potentially greater cardiac morbidity and mortality compared to other breeds.[4](#jvim14759-bib-0004){ref-type="ref"}, [5](#jvim14759-bib-0005){ref-type="ref"}, [6](#jvim14759-bib-0006){ref-type="ref"} Yet, the preclinical period often varies markedly between dogs making it challenging for clinicians to identify dogs that will eventually succumb as a consequence of the disease.[3](#jvim14759-bib-0003){ref-type="ref"}, [7](#jvim14759-bib-0007){ref-type="ref"} Identification of this subpopulation of dogs at high risk of developing CHF, preferably at an early age, would have a number of advantages such as more targeted monitoring, and owner education on recognition of clinical signs. As studies indicate an inherited component to the disease in at least some of the highly susceptible breeds, early predictors would also allow for improved breeding recommendations.[8](#jvim14759-bib-0008){ref-type="ref"}, [9](#jvim14759-bib-0009){ref-type="ref"}, [10](#jvim14759-bib-0010){ref-type="ref"}, [11](#jvim14759-bib-0011){ref-type="ref"}, [12](#jvim14759-bib-0012){ref-type="ref"} In addition, unnecessary owner concern of short lifespan might be avoided for low‐risk dogs.[3](#jvim14759-bib-0003){ref-type="ref"} Thus, it is of great interest to identify risk factors and prognostic indicators associated with development, progression, and survival of dogs with MMVD. Previously studies have proposed a number of clinical and echocardiographic risk factors and prognostic indicators affecting survival.[2](#jvim14759-bib-0002){ref-type="ref"}, [13](#jvim14759-bib-0013){ref-type="ref"}, [14](#jvim14759-bib-0014){ref-type="ref"}, [15](#jvim14759-bib-0015){ref-type="ref"} However, many of these studies have been focusing on dogs at advanced stages of MMVD and it has been found that many of the echocardiographic variables do not change radically until late stages of MMVD.[16](#jvim14759-bib-0016){ref-type="ref"} Thus, information about risk factors and prognostic indicators at an early age is sparse.

The aim of the study was to investigate the predictive value of selected clinical and echocardiographic characteristics associated with MMVD for prediction of long‐term cardiac and all‐cause mortality in CKCS before the age of 3 years.

Materials and Methods {#jvim14759-sec-0008}
=====================

The medical records of all client‐owned CKCS presented for echocardiographic evaluation at the Department of Veterinary Disease Biology, University of Copenhagen, between January 1, 1996, and June 30, 2012, were reviewed retrospectively.

Dogs between 1 and 3 years of age were evaluated for prebreeding cardiac screening, cardiac health check, or participation in previous cross‐sectional research projects. All owners provided written or oral informed consent.

All dogs underwent owner interview, clinical examination, standardized echocardiographic examination, and electrocardiography (ECG). The following clinical data were recorded: sex, age, coat color, date of birth, body weight (BW), presence, and grade of heart murmur. None of the dogs were sedated and owners were present during the entire examination. Based on auscultation, mitral regurgitation murmur intensity was graded 1--6.[17](#jvim14759-bib-0017){ref-type="ref"} Intermittent murmurs and physiological flow murmurs (diagnosed as systolic murmurs with crescendo‐decrescendo sound configuration, point of maximal intensity at the left heart base, and mild or no concurrent MR found by color flow Doppler echocardiography[18](#jvim14759-bib-0018){ref-type="ref"}) were registered.

Echocardiography and Electrocardiography {#jvim14759-sec-0009}
----------------------------------------

Standardized transthoracic echocardiography with continuous ECG monitoring from parasternal and apical windows[19](#jvim14759-bib-0019){ref-type="ref"} including 2D, M‐mode, and color flow Doppler was performed on all dogs. All examinations were performed by 2 experienced echocardiographers. Commercially available ultrasound units[1](#jvim14759-note-1004){ref-type="fn"} and transducers were used. If more than 1 echocardiographic examination had been conducted before the age of 3, the most recent examination was used for this study. Recorded echocardiograms were analyzed off‐line in a random order blinded for outcome of the dogs by 1 observer (MJR) either digitally[2](#jvim14759-note-1005){ref-type="fn"} or from videotape recordings transferred to digital files. Images of inadequate quality were excluded. The observer was blinded to all clinical data except date of birth of the dog during analysis of echocardiograms. In randomly selected dogs, measurements were repeated by the same observer (6 times; n = 6 dogs) and by a second observer (LHO) (n = 30). Severity of MR was assessed on color flow Doppler recordings from left apical four‐chamber view and classified as no (0%), mild (\<20%), moderate (20--50%), severe (\>50%), or intermittent based on maximal systolic regurgitant jet area relative to left atrial area.[20](#jvim14759-bib-0020){ref-type="ref"} Intermittent MR was defined as no or mild MR in the majority of cardiac systoles but with some MR jets ≥20%.[20](#jvim14759-bib-0020){ref-type="ref"} The degree of mitral valve prolapse (MVP) was evaluated from the right parasternal long‐axis four‐chamber view and graded: none (≤1 mm total MVP sum of anterior leaflet, posterior leaflet, and coaptation point protrusion into LA in systole according to annulus plane in increments of 1 mm), mild (2--4 mm), moderate (5--7 mm), or severe (≥8 mm).[20](#jvim14759-bib-0020){ref-type="ref"}, [21](#jvim14759-bib-0021){ref-type="ref"} Left atrial‐to‐aortic root ratio (LA/Ao) was assessed from right parasternal short‐axis view measured at first frame after closure of the aortic valve at the level of the aortic root as previously described.[22](#jvim14759-bib-0022){ref-type="ref"} Left ventricular (LV) dimensions were measured from the right parasternal short‐axis view using M‐mode at the level of the chordae tendineae[19](#jvim14759-bib-0019){ref-type="ref"}: LV end‐diastolic and end‐systolic internal dimensions (LVIDD, LVIDS) and LV posterior wall thickness end‐diastolic dimension (LVPWD). Left ventricular internal dimensions were normalized to body weight (BW)[23](#jvim14759-bib-0023){ref-type="ref"} and fractional shortening (FS) was calculated.[24](#jvim14759-bib-0024){ref-type="ref"} The *h/R* ratio representing diastolic LV posterior wall thickness (*h* = LVPWD) relative to LV internal diastolic radius (*R* = LVIDD/2) was calculated as described elsewhere.[25](#jvim14759-bib-0025){ref-type="ref"} All quantitative echocardiographic variables were based on mean of 3 measurements. Heart rate was recorded from a separate ECG paper recording that was performed after the initial part of the echocardiographic examination with the dog in right lateral recumbency by counting number of R--R intervals per 15 seconds.

Follow‐Up {#jvim14759-sec-0010}
---------

Standardized telephone interviews were conducted between December 1, 2012, and June 30, 2013, with dog owners to determine the current health status of each dog. Dogs between 1 and 3 years that had been echocardiographically examined at the Department of Veterinary Disease Biology, University of Copenhagen, within the last year (between June 30, 2012, and June 30, 2013) were not included as health status was considered the same as at the last examination. Likewise, owners of older dogs that had been re‐examined at the Department of Veterinary Disease Biology, University of Copenhagen, within the last year were not contacted, but instead information from the medical records was used as health status was considered the same as at their last examination. A questionnaire with a number of predefined possible answers modified from Borgarelli et al.[3](#jvim14759-bib-0003){ref-type="ref"}, [15](#jvim14759-bib-0015){ref-type="ref"} was used. The interviewer was blinded to the clinical status of the dog at the initial examination. The owner was asked whether the dog was dead or alive. If the dog was dead, the owner was asked at what age death had occurred, whether the dog had been euthanized or died spontaneously, cause of death/reason for euthanasia, whether the dog had received cardiac treatment (including period of time receiving cardiac treatment and clinical effect), and whether the dog had clinical signs of CHF (including dyspnoea, breathlessness, nocturnal restlessness, frequent coughing, exercise intolerance, and syncope). Dogs were then allocated into the following groups depending on presumed cause of death: cardiac death or noncardiac death. Cardiac death was defined as death or euthanasia due to clinical signs of CHF or diagnosis of CHF by local veterinarian with or without diagnostics and response to cardiac treatment, sudden death with no other evident cause, death in anesthesia with previous cardiac signs, or euthanasia by authors due to refractory CHF. Sudden death was defined as death occurring within 1 hour after onset of clinical signs or a dog found dead by owner when arriving home. All other deaths were recorded as noncardiac‐related.

Statistical Analysis {#jvim14759-sec-0011}
--------------------

Statistical software[3](#jvim14759-note-1006){ref-type="fn"} was used for data analysis and a *P* value of \<0.05 was considered significant unless otherwise stated.

For descriptive statistics, dogs were divided into 4 groups: those that were alive, those dead due to heart disease, those dead due to other causes, and those that were lost to follow‐up. Data are reported as medians and interquartile ranges.

By Cox proportional hazard analysis, the effects on survival of the following variables were evaluated: sex, body weight (BW), coat color, MR group, MVP group, murmur, heart rate, LA/Ao, LVIDD normalized for BW (LVIDD~N~), LVIDS normalized for BW (LVIDS~N~), LVPWD, FS, and *h/R*. Age was used as timescale with entry at 3 years of age (delayed entry), ensuring that all dogs have the measurements performed. Dogs that were alive at the end of the study period were right‐censored. For the purpose of statistical analysis, the following groups were combined due to low numbers: MR groups moderate (n = 118) and severe (n = 8) to group MR moderate‐severe, MVP groups moderate (n = 183) and severe (n = 10) to group MVP 2, and finally murmur groups 1 (n = 23), intermittent 1 (n = 5), 2 (n = 19), and 3--6 (n = 0) to group murmur \>0. The primary endpoints of the study were death and analyses were performed for all‐cause and cardiac death. Dogs dying from a combination of 2 or more causes (including a cardiac related cause) (n = 14) are listed as "combined" and thus are not included in statistical analysis as cardiac deaths.

Because the study was performed over several years, a period variable with 3 categories (1996--2001, 2002--2007, and 2008--2012) indicating the date of echocardiography was constructed. All significant variables in the 2 Cox proportional hazard analyses (the 1 for all‐cause and the 1 for cardiac death) were tested for interactions with the period variable, but none were found.

For descriptive purposes, univariate Cox proportional hazard analyses were performed. The primary analyses was multivariate Cox proportional hazard analyses including relevant interactions (sex\*MR group, sex\*MVP group, and sex\*murmur group). A combination of forward inclusion and backward elimination was applied to form a final model. The proportional hazards assumption as well as the assumption of log‐linear effect of continuous explanatory variables was investigated using cumulative martingale residuals.[26](#jvim14759-bib-0026){ref-type="ref"}

By the Kaplan‐Meier method, survival curves and median survival times with 95% confidence intervals (95% CI) were estimated for all‐cause mortality.

The obtained multivariate Cox proportional hazard model for cardiac death was used to construct cumulative incidence curves for different combinations of MR and sex and all other variables that proved significant for mortality in the multivariable analyses set at their median values.

Differences between all variables for follow‐up dogs and dogs lost to follow‐up were tested by logistic regression using the variable lost to follow‐up (yes/no) as response variable (see Table [S1](#jvim14759-sup-0002){ref-type="supplementary-material"}).

Inter‐ and intraobserver variability coefficients of variation are also included in Table [S2](#jvim14759-sup-0002){ref-type="supplementary-material"}.

Results {#jvim14759-sec-0012}
=======

The study population included a total of 1125 CKCS. Figure [1](#jvim14759-fig-0001){ref-type="fig"} illustrates the exclusion of dogs. Baseline characteristics and echocardiographic values of the final study population are listed in Table [1](#jvim14759-tbl-0001){ref-type="table-wrap"}. Of the 906 CKCS that had their status recorded, 288 died or were euthanized during the follow‐up period. Of these 74 (26%) were considered cardiac deaths. Of the 74 cardiac deaths, 31 (42%) died a sudden death (15 males and 16 females). There were 214 (74%) CKCS that died/were euthanized due to noncardiac causes. The median period of follow‐up was 3.1 years (quartile 1‐quartile 3, 1.5--5.4). Figures [2](#jvim14759-fig-0002){ref-type="fig"} and [S1](#jvim14759-sup-0001){ref-type="supplementary-material"} show the different causes of death in males and females.

![Flowchart illustrating reasons for exclusion of study dogs.](JVIM-31-1008-g001){#jvim14759-fig-0001}

###### 

Dog characteristics and conventional echocardiographic variables for 1020 CKCS allocated according outcome in 2013

  Variable                    n      Alive (1)          Cardiac death (2)   Non‐cardiac death (3)   Lost to follow‐up (4)
  --------------------------- ------ ------------------ ------------------- ----------------------- -----------------------
  Number of CKCS              1020   618                74                  214                     114
  Age at examination (days)   1020   640 (571;749)      745 (603;914)       726 (597;863)           650 (563;844)
  Sex (f/m)                   1020   404/214            41/33               137/77                  72/42
  Color (bh, bt, rb, tri)     1020   217/146/124/131    30/11/10/23         84/31/33/66             42/17/23/32
  BW (kg)                     1020   8.2 (7.3;8.3)      8.4 (7.4;9.6)       8.2 (7.4;9.3)           8.4 (7.2;9.6)
  MR (no/mild/mod‐se/int)     1015   282/200/63/72      15/27/16/14         70/83/23/36             41/38/24/11
  MVP (0/1/2)                 1017   68/430/119         16/42/16            26/155/32               9/78/26
  Murmur (0/\>0/f)            1020   570/11/37          57/11/6             164/18/32               92/7/15
  Heart rate (beats/min)      968    120 (102;144)      120 (102;132)       114 (102;132)           120 (102;141)
  LA/Ao                       1002   1.2 (1.1;1.3)      1.2 (1.1;1.2)       1.2 (1.1;1.2)           1.1 (1.0;1.2)
  LVIDD~N~                    1015   1.5 (1.4;1.5)      1.4 (1.3;1.5)       1.4 (1.3;1.5)           1.4 (1.3;1.5)
  LVIDS~N~                    1015   0.9 (0.9;1.0)      1.0 (0.9;1.0)       0.9 (0.8;1.0)           0.9 (0.8;1.0)
  LVPWD                       1015   0.7 (0.6;0.8)      0.7 (0.6;0.8)       0.7 (0.6;0.8)           0.7 (0.6;0.8)
  FS (%)                      1015   32.7 (28.6;36.3)   30.6 (27.6;36.0)    32.4 (28.3;37.1)        32.4 (28.0;37.7)
  h/R                         1015   0.5 (0.5;0.6)      0.5 (0.5;0.6)       0.5 (0.5;0.6)           0.5 (0.5;0.6)

BW, body weight; CKCS, Cavalier King Charles Spaniels; color, coat color where bh, blenheim; bt, black and tan; rb, ruby, tri, tricolor; FS, fractional shortening; h/R, LV posterior wall thickness relative to internal diastolic radius; LA/Ao, ratio of left atrium to aortic root; LVIDD~N~, left ventricular end‐diastolic diameter normalized for BW; LVIDS~N~, left ventricular end‐systolic diameter normalized for BW; LVPWD, left ventricular free wall thickness in diastole; MR, mitral regurgitation group where no = no (0%), mild, mild (\<20%), mod‐se, moderate‐severe (20--100%), int, intermittent (most often mild MR but some MR jets ≥ 20%); MVP, mitral valve prolapse group where 0 = ≤1 mm total MVP, 1 = 2‐4 mm total MVP, 2 = ≥5 mm total MVP; murmur, mitral regurgitation murmur intensity group where 0 = no murmur, \>0 = murmur 1--6, f = flow murmur. Values reported are median and interquartile ranges.
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![Histogram showing causes of death in the 288 CKCS. Other includes: old age (males = 2; females = 9), toxic (males = 1; females = 3), endocrinology (males = 2; females = 0), gastrointestinal (males = 3; females = 1), unspecified (males = 2; females = 7), anesthesia without previous cardiac clinical signs (males = 0; females = 3), ocular (males = 4; females = 3), immune‐mediated (males = 0; females = 4), auditory and integument (males = 2; females = 1), respiratory (males = 1; females = 1), kidney/liver/pancreas (males = 2; females = 10), iatrogen (males = 1; females = 0), combination of 2 or more categories including cardiovascular (males = 5; females = 9), combination of 2 or more categories excluding cardiovascular (males = 4; females = 12).](JVIM-31-1008-g002){#jvim14759-fig-0002}

Survival Analyses {#jvim14759-sec-0013}
-----------------

Table [2](#jvim14759-tbl-0002){ref-type="table-wrap"} shows univariable predictors of all‐cause mortality and cardiac death.

###### 

Results of univariable Cox proportional hazard analyses of factors predictive for survival (all‐cause and cardiac mortality) in 906 CKCS

                  All‐Cause Mortality   Cardiac Death                                                   
  --------------- --------------------- ------------------- ------------- -------- -------------------- -------------
  MR group        901/284                                                 901/72                        
  mild vs. no                           0.95 (0.72;1.27)    0.75                   1.30 (0.69;2.44)     0.42
  mod‐se vs. no                         1.25 (0.86;1.83)    0.24                   2.81 (1.39;5.69)     **0.0041**
  int vs. no                            1.11 (0.78;1.58)    0.57                   1.72 (0.83;3.56)     0.15
  MVP             904/287                                                 904/74                        
  1 vs. 0                               1.08 (0.77;1.51)    0.66                   0.60 (0.34;1.08)     0.087
  2 vs. 0                               1.38 (0.91;2.12)    0.13                   1.20 (0.59;2.44)     0.61
  Murmur          906/288                                                 906/74                        
  \>0 vs. 0                             0.91 (0.61;1.35)    0.63                   1.27 (0.66;2.45)     0.48
  f vs. 0                               1.21 (0.86;1.71)    0.28                   0.69 (0.30;1.60)     0.38
  Heart rate      863/275               0.99 (0.99;1.00)    **0.021**     863/71   1.00 (0.99;1.01)     0.88
  Sex (males)     906/288               1.15 (0.90;1.46)    0.263         906/74   1.44 (0.91;2.27)     0.12
  Color           906/288                                                 906/74                        
  Bt vs. Bh                             0.86 (0.60;1.23)    0.41                   0.87 (0.44;1.74)     0.70
  Rb vs. Bh                             0.99 (0.69;1.41)    0.95                   0.97 (0.47;1.98)     0.93
  Tri vs. Bh                            1.16 (0.88;1.54)    0.29                   1.09 (0.63;1.88)     0.76
  BW              906/288               1.01 (0.94;1.09)    0.80          906/74   1.02 (0.88;1.18)     0.78
  LA/Ao           894/285               0.36 (0.098;1.35)   0.13          894/74   0.12 (0.0093;1.58)   0.11
  LVIDD~N~        901/285               1.03 (0.95;1.11)    0.50          901/74   1.12 (0.96;1.29)     0.14
  LVIDS~N~        901/285               1.14 (1.04;1.25)    **0.0052**    901/74   1.33 (1.12;1.57)     **0.0010**
  LVPWD           901/285               0.96 (0.86;1.08)    0.51          901/74   0.88 (0.70;1.10)     0.26
  FS              901/285               0.96 (0.94;0.98)    **\<0.001**   901/74   0.93 (0.90;0.97)     **\<0.001**
  h/R             901/285               0.76 (0.21;2.73)    0.68          901/74   0.15 (0.011;2.01)    0.15

BW, body weight; CKCS, Cavalier King Charles Spaniels; color, coat color where bh, blenheim; bt, black and tan; rb, ruby; tri, tricolor; FS, fractional shortening; h/R, LV posterior wall thickness relative to internal diastolic radius; LA/Ao, ratio of left atrium to aortic root; LVIDD~N~, left ventricular end‐diastolic diameter normalized for BW; LVIDS~N~, left ventricular end‐systolic diameter normalized for BW; LVPWD~N~, left ventricular free wall thickness in diastole normalized for BW; MR, mitral regurgitation group where no = no (0%), mild, mild (\<20%), moderate‐se, moderate‐severe (20--100%), int, intermittent (most often mild MR but some MR jets ≥20%); MVP, mitral valve prolapse group where 0 = ≤1 mm total MVP, 1 = 2--4 mm total MVP, 2 = ≥5 mm total MVP; murmur, mitral regurgitation murmur intensity group where 0 = no murmur, \>0 = murmur 1--6, f = flow murmur. Bold values are statistically significant.
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Based on the results from univariable analysis, the following variables were considered for multivariable modeling: LVIDS~N~, LA/Ao, FS, heart rate, MR group, MVP group, and sex. Collinearity (Spearman\'s correlation of −0.59) was found between FS and LVIDS~N~. As LVIDS~N~ was the best predictor concerning cardiac death, this variable was chosen for multivariate analysis. A statistically significant interaction between MR group and sex was found. All multivariable analyses (all‐cause and cardiac mortality) were performed including the explanatory variables: LVIDS~N~, LA/Ao, heart rate, MVP group, and the interaction between MR group and sex. When adjusting for the other explanatory variables, heart rate and MVP group were no longer significant for all‐cause or cardiac mortality, Table [3](#jvim14759-tbl-0003){ref-type="table-wrap"}.

###### 

Results of multivariable Cox proportional hazard analyses of factors predictive of survival in 906 CKCS

  Variable                   All‐cause mortality   Cardiac death                         
  -------------------------- --------------------- --------------- --------------------- -------------
  LVIDSN                     1.13 (1.02;1.24)      **0.016**       1.37 (1.14;1.63)      **\<0.001**
  LA/Ao                      0.17 (0.044;0.68)     **0.012**       0.045 (0.0030;0.69)   **0.026**
  MR\*sex                    --                    **0.035**       --                    0.99
  MR group                   --                    --              1.51 (0.78;2.90)      0.22
  mild vs. no                                                      3.03 (1.48;6.23)      **0.0025**
  mod‐se vs. no int vs. no                                         2.23 (1.04;4.79)      **0.039**

95% CI, 95% confidence interval; HR, hazard ratio; LA/Ao, ratio of left atrium to aortic root; LVIDS~N~, left ventricular end‐systolic diameter normalized for BW; MR, mitral regurgitation group where no = no (0%), mild, mild (\<20%), moderate‐se, moderate‐severe (20--100%); int, intermittent (most often mild MR but some MR jets ≥20%). Bold values are statistically significant.

John Wiley & Sons, Ltd

A higher value of LVIDS~N~ at examination between 1 and 3 years of age significantly increased the hazard of cardiac and all‐cause mortality. Dogs with moderate to severe MR and intermittent MR had significantly increased hazard of cardiac death compared to dogs with no MR. Counterintuitively, a lower value of LA/Ao at examination between 1 and 3 years of age significantly increased the hazard of cardiac and all‐cause mortality.

The interaction between MR group and sex was significant for all‐cause mortality but not cardiac death. Males with moderate to severe MR had significantly increased hazard ratio of death compared to males with no MR (hazard ratio = 2.38, 95% CI = 1.27--4.49, *P* = 0.0071) whereas there was no significant differences between MR groups for females, Fig. [3](#jvim14759-fig-0003){ref-type="fig"}.

![Kaplan‐Meier curves for all‐cause mortality given for each combination of sex (top = females, bottom = males) and mitral regurgitation (MR) group where black curve represents no MR = 0%, red curve represents mild MR (\<20%), green curve represents moderate (20--50%)‐severe (\>50%) MR, and blue curve represents intermittent MR (most often mild MR but some MR jets ≥20%).](JVIM-31-1008-g003){#jvim14759-fig-0003}

Figure [4](#jvim14759-fig-0004){ref-type="fig"} shows cumulative incidence curves for cardiac death, demonstrating that having moderate to severe MR at 1--3 years age or presence of intermittent MR is associated with increased risk of cardiac death.

![Cumulative incidence curves for cardiac death given for each combination of sex (top = females, bottom = males) and mitral regurgitation (MR) group where black curve represents no MR = 0%, red curve represents mild MR (\<20%), green curve represents moderate (20--50%)‐severe (\>50%) MR, and blue curve represents intermittent MR (most often mild MR but some MR jets ≥ 20%). The remaining variables are set at their median values (LVIDS~N~ = 0.93, LA/Ao = 1.2, and HR = 120).](JVIM-31-1008-g004){#jvim14759-fig-0004}

Discussion {#jvim14759-sec-0014}
==========

The results of the present study show that presence of more than mild MR even if intermittent on echocardiography in CKCS aged 1--3 years was associated with increased risk of cardiac death. This was especially true for male dogs. Finally, even though MMVD generally is considered a relatively benign condition, a relatively large proportion (more than one‐fourth) of the CKCS deaths in the present study were due to cardiac causes.

To minimize variability, the present study followed a standardized protocol at the same research facility and only very few operators and observers were included. Furthermore, a large number of dogs were included and all dogs were of the same breed. Surprisingly, only few variables were predictive of mortality. Yet, this is probably in part due to the very young age at which the dogs were examined.

As expected, more severe MR at examination at young age was associated with increased cardiac mortality in CKCS. This was however not the case when MR was based on murmur intensity on auscultation underlining the importance of assessment of MR using cardiac ultrasound.[15](#jvim14759-bib-0015){ref-type="ref"}, [18](#jvim14759-bib-0018){ref-type="ref"} In accordance with the present study, previous studies evaluating murmur intensity also found limited prognostic significance of low‐grade murmurs.[27](#jvim14759-bib-0027){ref-type="ref"}, [28](#jvim14759-bib-0028){ref-type="ref"} In the present study, flow murmurs do not appear to have any prognostic significance either. There are a number of ongoing breeding programs aimed at decreasing the prevalence of MMVD in CKCS in several different countries.[12](#jvim14759-bib-0012){ref-type="ref"}, [29](#jvim14759-bib-0029){ref-type="ref"}, [30](#jvim14759-bib-0030){ref-type="ref"} These programs are mostly based on identification of MR using auscultation but some also include echocardiography (estimating the degree of MVP) and parental information. A recent study concerning the Danish breeding program for CKCS based on auscultation and echocardiography did find a decrease in prevalence of MMVD; however, it was unclear whether auscultation, echocardiography (estimating the degree of MVP), or the fact that the program was mandatory contributed most to this effect.[12](#jvim14759-bib-0012){ref-type="ref"} Yet, based on the results from the present study, it could seem that adding echocardiographic information estimating the degree of MR to the breeding evaluation might be useful. It is important to be aware of the fact that color flow Doppler echocardiography is a semiquantitative estimate influenced by factors such as echocardiographic equipment and technical settings.[31](#jvim14759-bib-0031){ref-type="ref"} However, other methods of estimating MR size such as calculation of the effective regurgitant orifice area (EROA) using the proximal isovelocity surface area (PISA) or vena contracta are not always possible to achieve in mild cases of MR.

Interestingly, presence of echocardiographic intermittent MR was also associated with increased cardiac mortality. The nature of intermittent MR is generally poorly characterized and the clinical importance of this phenomenon has not previously been studied in dogs[20](#jvim14759-bib-0020){ref-type="ref"} and has not been described in human patients. A surprising and interesting finding was that intermittent MR but not mild MR was associated with cardiac mortality, considering that the MR in intermittent MR was mild in most heart beats. A possible explanation might be that the single heart beats with more severe MR mediates valvular shear stress that influences disease progression or that the atrium cannot handle the more severe MRs that suddenly occur. A previous study found intermittent MR to be associated with variations in R--R interval.[20](#jvim14759-bib-0020){ref-type="ref"} Thus, another hypothesis is that intermittent MR might represent moderate or severe MR masked by a variation in R--R interval or heart rate. These hypotheses would imply that intermittent MRs should be considered as serious as the maximal MR observed instead of the MR that is most often observed. Thus, intermittent MR or intermittent murmurs might be warning sign that warrant more close surveillance of a patient. It is unknown whether the size of the intermittent MR is important in relation to progression of MMVD, and whether intermittent MR is an early manifestation of progression to more advanced MR. Thus, further studies are needed to clarify the importance of this phenomenon.

The fact that MR group (as an interaction with sex) was also associated with all‐cause mortality may seem odd, but it probably is a consequence of the relationship between cardiac death and all‐cause mortality.

In dogs with MMVD, previous studies have suggested MVP to have prognostic significance.[27](#jvim14759-bib-0027){ref-type="ref"}, [28](#jvim14759-bib-0028){ref-type="ref"}, [32](#jvim14759-bib-0032){ref-type="ref"} The fact that MVP was not associated with survival in the present study does not imply that MVP should not be used as an early risk factor for MMVD and cardiac death. As the vast majority of the CKCS had some degree of MVP, and relative few dogs had no or severe MVP, it can be difficult to show significant differences associated with MVP. Furthermore, in the present study, the consequences of MVP (which is MR) did have prognostic significance.

Higher LVIDS~N~ (and lower FS) was associated with a higher all‐cause and cardiac mortality. This is an interesting finding. It may be hypothesized that this finding could indicate a systolic dysfunction at a very early age in CKCS. However, the clinical significance of the finding remains uncertain as the values of both LVIDS~N~ and FS were generally within reference ranges of normal dogs[13](#jvim14759-bib-0013){ref-type="ref"}, [20](#jvim14759-bib-0020){ref-type="ref"}, [33](#jvim14759-bib-0033){ref-type="ref"} Previous studies have found systolic LV dimensions to have predictive value for survival, but to the authors knowledge, this has not be evaluated previously in CKCS this young.[3](#jvim14759-bib-0003){ref-type="ref"}, [16](#jvim14759-bib-0016){ref-type="ref"}, [25](#jvim14759-bib-0025){ref-type="ref"}, [34](#jvim14759-bib-0034){ref-type="ref"} In human patients with MR, severe LV dilatation with increased chamber dimensions is associated with poor prognosis and considered important for timing of surgical intervention.[35](#jvim14759-bib-0035){ref-type="ref"}

Decreased LA/Ao ratio was also found to be associated with a higher all‐cause and cardiac mortality. This was not expected and counterintuitive as it is generally accepted that increasing LA/Ao is a risk factor in MMVD.[3](#jvim14759-bib-0003){ref-type="ref"}, [13](#jvim14759-bib-0013){ref-type="ref"}, [15](#jvim14759-bib-0015){ref-type="ref"}, [36](#jvim14759-bib-0036){ref-type="ref"} Again, it should be kept in mind that the dogs are very young and that all LA/Ao values were within a very narrow range and all within reference ranges of normal dogs[37](#jvim14759-bib-0037){ref-type="ref"} and thus could represent a finding occurring at random.

Myxomatous mitral valve disease generally is considered a relatively benign condition. Yet, in the present study a relatively large proportion of the CKCS deaths were due to cardiac causes (26%). In the present study, life time could not be estimated as dogs were included at the age of 3, meaning that the life time would be overestimated as dogs dying before 3 years of age were excluded. However, data suggested (Fig [4](#jvim14759-fig-0004){ref-type="fig"}) that cardiac mortality does not begin to increase before the age of 7 years and that many dogs survive longer than that. In addition, we found that dogs with moderate to severe MR even when intermittent had increased risk of death and that this was especially true for male dogs. This is in accordance with previous studies indicating that MMVD in male dogs is more common and progress faster.[8](#jvim14759-bib-0008){ref-type="ref"}, [9](#jvim14759-bib-0009){ref-type="ref"}, [38](#jvim14759-bib-0038){ref-type="ref"} Further, data suggest (Fig [3](#jvim14759-fig-0003){ref-type="fig"}) that males have a trend toward higher all‐cause mortality rate with approximately 60% of male CKCS dying before the age of 10 years compared to only approximately 50% of the females.

Generally, the dogs lost to follow‐up were dogs that changed owner. There were differences in few echocardiographic measurements between CKCS included in survival analysis and CKCS lost to follow‐up (see Table [S1](#jvim14759-sup-0002){ref-type="supplementary-material"}). This comparison was made to assess for selection bias. It is unclear how this may have influenced our findings.

Limitations of the study include selection bias as dogs were privately owned and chosen from a database of CKCS used primarily for breeding purposes. This is also the reason that more female CKCS were included compared to males.

Furthermore, due to the retrospective nature of the present study, it was challenging to classify cause of death (based primarily on owner statements) and a proportion of the deaths may have been inaccurately classified. Many dogs had died a long time ago and many owners had more than 1 dog, and thus, it may have been a problem for the owner to remember the actual circumstances. In addition, in the majority of the cases, the diagnosis was based on findings from the owners' local veterinarian and often diagnoses were quite unspecific and/or based on only few diagnostic tests. Clinical signs are often difficult to differentiate from other conditions of elderly dogs and coughing and exercise intolerance may as well be a sign of bronchitis and osteoarthritis. Often the decision to euthanize a dog is multifactorial and the extent to which heart disease played a part is impossible to determine. In the present study, CKCS euthanized because of a combination of cardiac signs and other problems (n = 14) were assigned to a "combined causes" category and thus did not figure as cardiac deaths. Similarly, 2 dogs were euthanized because of a poor result at their prebreeding cardiac examination and these dogs were assigned to the "owner/behavior" category (see Fig [2](#jvim14759-fig-0002){ref-type="fig"}). A number of CKCS were euthanized because of neurologic signs that the local veterinarian assigned to epilepsy, cerebral hemorrhage, or thrombosis. These signs could be misdiagnosed syncope or results of cardiac disease as thrombus formation is a known complication of heart disease. Therefore, it could be argued that these dogs should have been categorized as cardiac deaths. In contrast, other diseases than heart disease without previous clear signs might have resulted in sudden death (i.e, subclinical neoplasia or intracranial problems), thus causing overestimation of cardiac related death. In the present study, it was not possible to differentiate types of cardiac disease in this study, but given the high prevalence of MMVD in CKCS, it is assumed that the majority of cardiac deaths were due to MMVD.[1](#jvim14759-bib-0001){ref-type="ref"}, [4](#jvim14759-bib-0004){ref-type="ref"}

An additional limitation is the effect of time that may have influenced results in several ways. All off‐line echocardiographic analyses were performed by a single observer. Furthermore, no interactions were found with the period variable and any of the significant variables in the Cox proportional hazard analyses. However, the operators performing auscultation and echocardiography (even though they were highly experienced) and echocardiographic equipment did change few times over time. This is especially of concern for color flow Doppler echocardiography which is a semiquantitative estimate influenced by a number of factors such as echocardiographic equipment, technical settings, flow direction, and blood pressure.[31](#jvim14759-bib-0031){ref-type="ref"}, [39](#jvim14759-bib-0039){ref-type="ref"}

Estimation of MR by the jet area method with color flow Doppler echocardiography is not optimal. However, gold standard methods requiring anesthesia of the dog, for example, cardiac magnetic resonance imaging were not possible in the present study.

Differentiation between intermittent MR and mild MR can be very challenging because movement of the heart during systole might change the plane of scan, and thus, mild MRs can disappear from the plane of scan and appear to be intermittent. Various apical planes are therefore beneficial to grade MR. However, the recordings available in the present study did not permit for more planes to be included in the echocardiographic evaluation. Further prospective studies are needed to clarify the presence and significance of intermittent MR.

Finally, the different follow‐up times of the dogs caused by the study design and fact that an ongoing breeding program with documented effect[12](#jvim14759-bib-0012){ref-type="ref"} was being carried out simultaneously may have influenced results.

Conclusions {#jvim14759-sec-0015}
===========

The present study indicates that presence of moderate to severe MR, intermittent moderate to severe MR, and increased LV systolic dimensions at 1--3 years of age are associated with increased cardiac mortality in CKCS later in life. Flow murmurs and mild MR did not influence cardiac mortality.

Supporting information
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###### 

**Figure S1**. Causes of death in 288 CKCS plotted according to age. Other includes: old age (males = 2; females = 9), toxic (males = 1; females = 3), endocrinology (males = 2; females = 0), gastrointestinal (males = 3; females = 1), unspecified (males = 2; females = 7), anesthesia without previous cardiac clinical signs (males = 0; females = 3), ocular (males = 4; females = 3), immune‐mediated (males = 0; females = 4), auditory and integument (males = 2; females = 1), respiratory (males = 1; females = 1), kidney/liver/pancreas (males = 2; females = 10), iatrogen (males = 1; females = 0), combination of 2 or more categories including cardiovascular (males = 5; females = 9), combination of 2 or more categories excluding cardiovascular (males = 4; females = 12). In 2 dogs the age of death was unknown.

###### 

Click here for additional data file.

###### 

**Table S1**. Statistically significant results of logistic regression analyses between follow‐up dogs and dogs lost to follow‐up.

**Table S2**. Inter‐ and intraobserver variability coefficients of variation of the echocardiographic variables.

###### 

Click here for additional data file.
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